{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:03:26Z","timestamp":1785769406226,"version":"3.56.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82225049, 71974138"],"award-info":[{"award-number":["82225049, 71974138"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72174132"],"award-info":[{"award-number":["72174132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72004148"],"award-info":[{"award-number":["72004148"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China","award":["2021YFC2701503"],"award-info":[{"award-number":["2021YFC2701503"]}]},{"name":"Sichuan Youth Science and Technology Innovation Research Team","award":["2020JDTD0015"],"award-info":[{"award-number":["2020JDTD0015"]}]},{"DOI":"10.13039\/100001547","name":"China Medical Board","doi-asserted-by":"publisher","award":["CMB19-324"],"award-info":[{"award-number":["CMB19-324"]}],"id":[{"id":"10.13039\/100001547","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Fundamental Research Funds for the Central public welfare research institutes","award":["2020YJSZX-3"],"award-info":[{"award-number":["2020YJSZX-3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10654-024-01124-6","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T03:41:11Z","timestamp":1712634071000},"page":"433-445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A population-based cohort of drug exposures and adverse pregnancy outcomes in China (DEEP): rationale, design, and baseline characteristics"],"prefix":"10.1007","volume":"39","author":[{"given":"Jing","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiquan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanhua","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyao","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6554-7088","authenticated-orcid":false,"given":"Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,9]]},"reference":[{"issue":"6","key":"1124_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3233\/jrs-1991-2606","volume":"2","author":"Collaborative Group On Drug Use In Pregnancy C","year":"1991","unstructured":"Collaborative Group On Drug Use In Pregnancy C. An international survey on drug utilization during pregnancy. Int J risk Saf Med. 1991;2(6):345\u20139. https:\/\/doi.org\/10.3233\/jrs-1991-2606.","journal-title":"Int J risk Saf Med"},{"issue":"1","key":"1124_CR2","doi-asserted-by":"publisher","first-page":"e511","DOI":"10.1016\/j.ajog.2011.02.029","volume":"205","author":"AA Mitchell","year":"2011","unstructured":"Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hern\u00e1ndez-D\u00edaz S. Medication use during pregnancy, with particular focus on prescription drugs: 1976\u20132008. Am J Obstet Gynecol. 2011;205(1):e511\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2011.02.029.","journal-title":"Am J Obstet Gynecol"},{"issue":"9844","key":"1124_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/s0140-6736(12)60468-1","volume":"380","author":"M Emanuel","year":"2012","unstructured":"Emanuel M, Rawlins M, Duff G, Breckenridge A. Thalidomide and its sequelae. Lancet (London England). 2012;380(9844):781\u20133. https:\/\/doi.org\/10.1016\/s0140-6736(12)60468-1.","journal-title":"Lancet (London England)"},{"issue":"7","key":"1124_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","volume":"79","author":"MH Bj\u00f8rk","year":"2022","unstructured":"Bj\u00f8rk MH, Zoega H, Leinonen MK, et al. Association of Prenatal Exposure to antiseizure medication with risk of Autism and Intellectual Disability. JAMA Neurol. 2022;79(7):672\u201381. https:\/\/doi.org\/10.1001\/jamaneurol.2022.1269.","journal-title":"JAMA Neurol"},{"issue":"5","key":"1124_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1365-2125.2008.03261.x","volume":"66","author":"O Diav-Citrin","year":"2008","unstructured":"Diav-Citrin O, Shechtman S, Weinbaum D, et al. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. Br J Clin Pharmacol. 2008;66(5):695\u2013705. https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03261.x.","journal-title":"Br J Clin Pharmacol"},{"key":"1124_CR6","doi-asserted-by":"publisher","unstructured":"Kmietowicz Z. Women are unaware of pregnancy risks linked with sodium valproate. BMJ (Clinical Res ed). 2016;355(i5829). https:\/\/doi.org\/10.1136\/bmj.i5829.","DOI":"10.1136\/bmj.i5829"},{"issue":"10","key":"1124_CR7","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/pds.3612","volume":"23","author":"D Mines","year":"2014","unstructured":"Mines D, Tennis P, Curkendall SM, et al. Topiramate use in pregnancy and the birth prevalence of oral clefts. Pharmacoepidemiol Drug Saf. 2014;23(10):1017\u201325. https:\/\/doi.org\/10.1002\/pds.3612.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"20","key":"1124_CR8","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1001\/jama.2018.17716","volume":"320","author":"K Heyrana","year":"2018","unstructured":"Heyrana K, Byers HM, Stratton P. Increasing the participation of pregnant women in clinical trials. JAMA. 2018;320(20):2077\u20138. https:\/\/doi.org\/10.1001\/jama.2018.17716.","journal-title":"JAMA"},{"issue":"7","key":"1124_CR9","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/pds.4789","volume":"28","author":"KF Huybrechts","year":"2019","unstructured":"Huybrechts KF, Bateman BT, Hern\u00e1ndez-D\u00edaz S. Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy. Pharmacoepidemiol Drug Saf. 2019;28(7):906\u201322. https:\/\/doi.org\/10.1002\/pds.4789.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1124_CR10","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Center for Biologics Evaluation and Research (CBER). Postapproval pregnancy safety studies guidance for industry. (2019-05). https:\/\/www.fda.gov\/media\/124746\/download."},{"key":"1124_CR11","unstructured":"S. H-D. Pregnancy registries. In: AHRQ, ed. Registries for Evaluating Patient Outcomes: A User\u2019s Guide: 3rd Edition 2014:135\u2013168."},{"key":"1124_CR12","unstructured":"Administration FD. Guidance for industry: establishing pregnancy exposure registries. 2002. https:\/\/www.fda.gov\/ucm\/groups\/fdagov-public\/@fdagov-drugs-gen\/documents\/document\/ucm071639.pdf."},{"issue":"2","key":"1124_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/aogs.12302","volume":"93","author":"J Langhoff-Roos","year":"2014","unstructured":"Langhoff-Roos J, Krebs L, Klungs\u00f8yr K, et al. The nordic medical birth registers\u2013a potential goldmine for clinical research. Acta Obstet Gynecol Scand. 2014;93(2):132\u20137. https:\/\/doi.org\/10.1111\/aogs.12302.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"1124_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2515\/therapie\/2014007","volume":"69","author":"R Charlton","year":"2014","unstructured":"Charlton R, Snowball J, Sammon C, de Vries C. The Clinical Practice Research Datalink for drug safety in pregnancy research: an overview. Therapie. 2014;69(1):83\u20139. https:\/\/doi.org\/10.2515\/therapie\/2014007.","journal-title":"Therapie"},{"key":"1124_CR15","doi-asserted-by":"publisher","unstructured":"Ailes EC, Simeone RM, Dawson AL, Petersen EE, Gilboa SM. Using insurance claims data to identify and estimate critical periods in pregnancy: an application to antidepressants. Birth defects research. Part A, clinical and molecular teratology. 2016;106(11):927\u201334. https:\/\/doi.org\/10.1002\/bdra.23573.","DOI":"10.1002\/bdra.23573"},{"issue":"1","key":"1124_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10654-018-0356-1","volume":"33","author":"M Bliddal","year":"2018","unstructured":"Bliddal M, Broe A, Potteg\u00e5rd A, Olsen J, Langhoff-Roos J. The Danish Medical Birth Register. Eur J Epidemiol. 2018;33(1):27\u201336. https:\/\/doi.org\/10.1007\/s10654-018-0356-1.","journal-title":"Eur J Epidemiol"},{"key":"1124_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/clep.S98139","volume":"8","author":"LH Pedersen","year":"2016","unstructured":"Pedersen LH, Petersen OB, N\u00f8rgaard M, et al. Linkage between the Danish National Health Service prescription database, the Danish fetal medicine database, and other Danish registries as a tool for the study of drug safety in pregnancy. Clin Epidemiol. 2016;8:91\u20135. https:\/\/doi.org\/10.2147\/clep.S98139.","journal-title":"Clin Epidemiol"},{"key":"1124_CR18","doi-asserted-by":"publisher","first-page":"879672","DOI":"10.3389\/fpubh.2022.879672","volume":"10","author":"C Zhu","year":"2022","unstructured":"Zhu C, Yan L, Wang Y, Ji S, Zhang Y, Zhang J. Fertility intention and related factors for having a second or third child among childbearing couples in Shanghai, China. Front Public Health. 2022;10:879672. https:\/\/doi.org\/10.3389\/fpubh.2022.879672.","journal-title":"Front Public Health"},{"key":"1124_CR19","doi-asserted-by":"publisher","unstructured":"Zhou Y, Mao X, Zhou H et al. Epidemiology of birth defects based on a birth defect surveillance system in Southern Jiangsu, China, 2014\u20132018. The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2022;35(4):745\u2009\u2013\u200951. https:\/\/doi.org\/10.1080\/14767058.2020.1731459.","DOI":"10.1080\/14767058.2020.1731459"},{"key":"1124_CR20","doi-asserted-by":"publisher","unstructured":"Zhiwen Li JD, China CDC, Weekly, Foreword. Prevention and Control of Birth Defects in China: Achievements and Challenges. https:\/\/weekly.chinacdc.cn\/en\/article\/doi\/https:\/\/doi.org\/10.46234\/ccdcw2021.1912021.","DOI":"10.46234\/ccdcw2021.1912021"},{"issue":"2","key":"1124_CR21","doi-asserted-by":"publisher","first-page":"e1003047","DOI":"10.1371\/journal.pmed.1003047","volume":"17","author":"X Zhang","year":"2020","unstructured":"Zhang X, Chen L, Wang X, et al. Changes in maternal age and prevalence of congenital anomalies during the enactment of China\u2019s universal two-child policy (2013\u20132017) in Zhejiang Province, China: an observational study. PLoS Med. 2020;17(2):e1003047. https:\/\/doi.org\/10.1371\/journal.pmed.1003047.","journal-title":"PLoS Med"},{"key":"1124_CR22","doi-asserted-by":"publisher","first-page":"k817","DOI":"10.1136\/bmj.k817","volume":"360","author":"J Liang","year":"2018","unstructured":"Liang J, Mu Y, Li X, et al. Relaxation of the one child policy and trends in caesarean section rates and birth outcomes in China between 2012 and 2016: observational study of nearly seven million health facility births. BMJ (Clinical Res ed). 2018;360:k817. https:\/\/doi.org\/10.1136\/bmj.k817.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"4","key":"1124_CR23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s12519-011-0326-0","volume":"7","author":"L Dai","year":"2011","unstructured":"Dai L, Zhu J, Liang J, Wang YP, Wang H, Mao M. Birth defects surveillance in China. World J Pediatrics: WJP. 2011;7(4):302\u201310. https:\/\/doi.org\/10.1007\/s12519-011-0326-0.","journal-title":"World J Pediatrics: WJP"},{"issue":"3","key":"1124_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10654-021-00831-8","volume":"37","author":"W Yue","year":"2022","unstructured":"Yue W, Zhang E, Liu R, et al. The China birth cohort study (CBCS). Eur J Epidemiol. 2022;37(3):295\u2013304. https:\/\/doi.org\/10.1007\/s10654-021-00831-8.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"1124_CR25","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1186\/s12884-021-04073-0","volume":"21","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Tao J, Wang K, et al. Protocol of a prospective and multicentre China Teratology Birth Cohort (CTBC): association of maternal drug exposure during pregnancy with adverse pregnancy outcomes. BMC Pregnancy Childbirth. 2021;21(1):593. https:\/\/doi.org\/10.1186\/s12884-021-04073-0.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1124_CR26","unstructured":"Statistics XBo. Xiamen City 2021 National Economic and Social Development Statistical Bulletin. http:\/\/tjj.xm.gov.cn\/tjzl\/ndgb\/202203\/t20220322_2636525.htm. 2022."},{"key":"1124_CR27","unstructured":"National Health Committee of People\u2018s Republic of China. China Drug Supply Information Platform. 2018. http:\/\/cdsip.nhc.gov.cn\/PriceBase\/YPIDList.aspx? key\u00bcypid&value&#188."},{"key":"1124_CR28","unstructured":"National Health and Family Planning Commission of of People\u2018s Republic of China. Women\u2019s health basic data set - part 6: birth defect surveillance, 2013. http:\/\/www.nhc.gov.cn\/ewebeditor\/uploadfile\/2018\/09\/20180921141035465.pdf."},{"key":"1124_CR29","unstructured":"China Maternal and Child Health Serveillance. China birth defects surveillance system: Guidelines for reporting complicated and micro malformations. 2012., http:\/\/www.mchscn.org\/admin\/wenjian\/wxjxbgbz-2012.pdf."},{"key":"1124_CR30","unstructured":"National Health Committee of People\u2018s Republic of China. 1 minute to understand the Congenital Structural Defects Program. 2019. http:\/\/www.nhc.gov.cn\/fys\/s3590\/201903\/9e08496ee740468a93764c4afd3ff4d8.shtml."},{"key":"1124_CR31","unstructured":"March of Dimes Birth Defects Foundation of China. Disease list of congenital metabolic defects program, 2017. http:\/\/www.csqx.org.cn\/content.aspx? id\u00bc381707814440."},{"key":"1124_CR32","unstructured":"Xie XKB, Duan T. Text book of Obstetrics and Gynecology (9th).Beijing: People\u2019s medical publishing house2018."},{"issue":"10","key":"1124_CR33","first-page":"925","volume":"31","author":"QYQH Deng","year":"2015","unstructured":"Deng QYQH. Normative definition of stillbirth and related registration procedures. Chin J Practical Obstet Gynecol. 2015;31(10):925\u20136. Chinese.","journal-title":"Chin J Practical Obstet Gynecol"},{"key":"1124_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","volume":"371","author":"RLCJ Goldenberg","year":"2008","unstructured":"Goldenberg RLCJ, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet (London England). 2008;371:75\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(08)60074-4.","journal-title":"Lancet (London England)"},{"key":"1124_CR35","unstructured":"Organization WH. International statistical classification of diseases and related health problems, 10th revision. https:\/\/icd.who.int\/browse10\/Content\/statichtml\/ICD10Volume2_en_2010.pdf. 2016."},{"issue":"5","key":"1124_CR36","doi-asserted-by":"publisher","first-page":"e219382","DOI":"10.1001\/jamanetworkopen.2021.9382","volume":"4","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, Yuan L, Wang J, et al. Mortality and morbidity of infants born extremely Preterm at Tertiary Medical Centers in China from 2010 to 2019. JAMA Netw open. 2021;4(5):e219382. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.9382.","journal-title":"JAMA Netw open"},{"issue":"5 Pt 1","key":"1124_CR37","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1097\/01.AOG.0000158858.79134.ea","volume":"105","author":"DM Marcus","year":"2005","unstructured":"Marcus DM, Snodgrass WR. Do no harm: avoidance of herbal medicines during pregnancy. Obstet Gynecol. 2005;105(5 Pt 1):1119\u201322. https:\/\/doi.org\/10.1097\/01.AOG.0000158858.79134.ea.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"1124_CR38","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/ptr.6020","volume":"32","author":"LO Bruno","year":"2018","unstructured":"Bruno LO, Simoes RS, de Jesus Simoes M, Gir\u00e3o M, Grundmann O. Pregnancy and herbal medicines: an unnecessary risk for women\u2019s health-A narrative review. Phytother Res. 2018;32(5):796\u2013810. https:\/\/doi.org\/10.1002\/ptr.6020.","journal-title":"Phytother Res"},{"issue":"4","key":"1124_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/pds.5412","volume":"31","author":"J Tazare","year":"2022","unstructured":"Tazare J, Wyss R, Franklin JM, et al. Transparency of high-dimensional propensity score analyses: Guidance for diagnostics and reporting. Pharmacoepidemiol Drug Saf. 2022;31(4):411\u201323. https:\/\/doi.org\/10.1002\/pds.5412.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1124_CR40","unstructured":"National Bureau of Statistics of China. Statistical Monitoring Report of the Program for the Development of Chinese Women (2021\u20132030), 2021. https:\/\/www.stats.gov.cn\/sj\/zxfb\/202312\/t20231229_1946062.html."}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-024-01124-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10654-024-01124-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-024-01124-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T09:28:22Z","timestamp":1715938102000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10654-024-01124-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1124"],"URL":"https:\/\/doi.org\/10.1007\/s10654-024-01124-6","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"18 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of West China Hospital of Sichuan University in China (No. 2019\u2009\u2212\u2009825, 2019\/10\/21).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"<b>and publish<\/b>.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"is waived due to the nature of retrospective data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}